| Ingredients | Amount Per Serving |
|---|---|
|
Cupric Gluconate
|
0.195 mcg |
| 0.195 mcg | |
|
Silver Nitrate
|
0.195 mcg |
Water, ethyl alcohol Note: 18% by vol.
Below is general information about the effectiveness of the known ingredients contained in the product Somaplex 18 Copper - Gold - Silver. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
There is insufficient reliable information available about the effectiveness of sodium tetrachloroaurate.
Below is general information about the safety of the known ingredients contained in the product Somaplex 18 Copper - Gold - Silver. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
There is insufficient reliable information available about the safety of sodium tetrachloroaurate.
PREGNANCY: POSSIBLY UNSAFE
when used orally or parenterally.
Sodium tetrachloroaurate is a gold salt. Evidence from animal models shows that the administration of other gold salts increases the risk of miscarriage and congenital abnormalities in the offspring (100534). Theoretically, sodium tetrachloroaurate may have similar adverse effects; avoid using.
LACTATION:
Insufficient reliable information available; avoid using.
Sodium tetrachloroaurate is a gold salt. There is evidence that gold is excreted in milk following the administration of other oral and injectable gold salts (100534). It is unclear if sodium tetrachloroaurate is excreted in breastmilk or what the possible adverse effects may be. Until more is known, avoid using.
Below is general information about the interactions of the known ingredients contained in the product Somaplex 18 Copper - Gold - Silver. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Below is general information about the adverse effects of the known ingredients contained in the product Somaplex 18 Copper - Gold - Silver. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General ...No adverse effects have been reported; however, a thorough evaluation of safety outcomes has not been conducted. Sodium tetrachloroaurate contains gold and might cause adverse effects similar to other gold salts. Orally, gold salts have been reported to cause gastrointestinal side effects, including diarrhea, loose stools, nausea, vomiting, and abdominal cramps. Ulcerative enterocolitis has also been reported, but this is rare. Orally and parenterally, gold salts may cause gold toxicity, with signs including aplastic anemia, low hemoglobin levels, leukopenia, granulocytopenia, immune thrombocytopenia, proteinuria, and hematuria (100534). Signs of liver injury and hepatotoxicity have also been reported, especially at higher doses (100535). Gold salts may also cause hypersensitivity (100536). Parenterally, gold salts commonly cause cutaneous reactions including pruritus and dermatitis. Chrysiasis may also occur (100534).
Dermatologic ...Parenterally, gold salts commonly cause cutaneous reactions including pruritus and dermatitis. Chrysiasis, which is an irreversible blue-gray discoloration of the skin, may also occur. Exposure to sunlight might worsen these reactions (100534). Sodium tetrachloroaurate is a gold salt and may theoretically cause similar adverse effects.
Gastrointestinal ...Orally, gold salts can cause stomatitis, which may be preceded by a metallic taste. Other adverse events including diarrhea, loose stools, nausea, vomiting, and abdominal cramps may also occur. Ulcerative enterocolitis has also been reported, but this is rare (100534). Sodium tetrachloroaurate is a gold salt and may theoretically cause similar adverse effects.
Hematologic ...Orally or parenterally, gold salts may cause gold toxicity, with signs including immune thrombocytopenia, leukopenia, granulocytopenia, and aplastic anemia (100534). Sodium tetrachloroaurate is a gold salt and may theoretically cause similar adverse effects.
Hepatic ...Orally and parenterally, gold salts have been associated with slight elevations in serum aminotransferase levels (100535). Parenterally, gold salts have also been associated with acute liver injury, although this is less common. Onset of injury seems to occur 1-8 weeks after starting therapy. Initial symptoms of liver injury include fever, rash, malaise, nausea, dark urine, and jaundice. Acute liver injury from gold therapy is typically associated with hypersensitivity. In rare cases, acute hepatocellular injury has been reported with high doses of gold salts (100535). Hepatic adverse effects have not been reported for sodium tetrachloroaurate; however, sodium tetrachloroaurate is a gold salt and may theoretically cause similar effects.
Immunologic ...Orally or parenterally, sodium tetrachloroaurate might cause adverse immune reactions. Gold (III) salts can cause oxidation of proteins, which may sensitize T cells and lead to hypersensitivity reactions (100536).
Renal ...Orally and parenterally, gold salts may cause nephrotic syndrome with proteinuria and hematuria. These adverse effects are typically mild, but may become severe and chronic if treatment is not discontinued after onset of the reaction (100534). Sodium tetrachloroaurate is a gold salt and may theoretically cause similar adverse effects.
